DENALI THERAPEUTICS INC's ticker is DNLI and the CUSIP is 24823R105. A total of 188 filers reported holding DENALI THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 2.00 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6 | -33.3% | 290 | -0.3% | 0.01% | -28.6% |
| Q2 2023 | $9 | +28.6% | 291 | -0.7% | 0.01% | +16.7% |
| Q1 2023 | $7 | -41.7% | 293 | -27.5% | 0.01% | +20.0% |
| Q4 2022 | $12 | -99.8% | 404 | +99.0% | 0.01% | 0.0% |
| Q3 2022 | $6,000 | – | 203 | +1461.5% | 0.01% | – |
| Q2 2022 | $0 | -100.0% | 13 | -95.0% | 0.00% | -100.0% |
| Q1 2022 | $8,000 | +14.3% | 258 | +66.5% | 0.01% | -50.0% |
| Q4 2021 | $7,000 | – | 155 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Crestline Management, LP | 19,462,500 | $339,037,000 | 35.95% |
| Euclidean Capital LLC | 323,749 | $27,117,000 | 5.74% |
| Flagship Pioneering Inc. | 2,730,263 | $228,687,000 | 4.16% |
| Casdin Capital, LLC | 1,310,000 | $109,726,000 | 3.25% |
| A.R.T. Advisors, LLC | 6,173 | $517,000 | 2.39% |
| MARK ASSET MANAGEMENT LP | 172,040 | $14,410,000 | 1.73% |
| Temasek Holdings (Private) Ltd | 4,410,457 | $369,420,000 | 1.59% |
| Integral Health Asset Management, LLC | 57,500 | $4,816,000 | 1.43% |
| GILDER GAGNON HOWE & CO LLC | 3,219,843 | $269,694,000 | 1.34% |
| IRONWOOD INVESTMENT MANAGEMENT LLC | 19,365 | $1,622,000 | 0.95% |